A Laparoscopic Grasping Instrument for Robust and Atraumatic Tissue Manipulation in Minimally-Invasive Gastrointestinal Surgery
腹腔镜抓取器械,用于微创胃肠手术中稳健且无创伤的组织操作
基本信息
- 批准号:10006295
- 负责人:
- 金额:$ 22.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-15 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AbdomenAddressAgingAnimalsAreaBlindedComplicationDataDevelopmentDevicesEvaluationFamilyFamily suidaeFutureGallbladderGastrointestinal Surgical ProceduresGoalsHeadHemorrhageIatrogenesisInfluenzaInjuryJawLampreysLaparoscopic CholecystectomyLaparoscopic Surgical ProceduresLaparoscopyLarge IntestineLeadLength of StayLiteratureMorbidity - disease rateMuscleOperative Surgical ProceduresPathologistPatientsPerceptionPerforationPhasePostoperative PainPostoperative PeriodProceduresPropertyPublicationsReportingResearchRiskRunningSafetySecureSeriesSmall Business Innovation Research GrantSmall IntestinesStainsStomachStructureSuctionSurgeonSystemTechniquesTestingTimeTissue MicroarrayTissue SampleTissuesTooth TissueTooth structureTraumatic injuryWorkaging populationbasecommercializationdesignexperienceflexibilitygraspiatrogenic injuryimprovedin vivoin vivo evaluationinstrumentminimally invasivenovelolder patientpatient populationsurgery outcometissue injurytoolusability
项目摘要
Abstract
With up to 4.8 million procedures annually in the U.S., laparoscopy has rapidly become the surgical standard for
a wide range of procedures. Compared to open procedures, laparoscopic approaches reduce muscle damage,
blood loss, post-operative pain, complication rates, and length of hospital stay. However, laparoscopy has unique
technique-specific limitations and complications, so the perception that minimally invasive surgery is minimally
traumatic is imprecise. There is now evidence that the frail, aging population may benefit most from laparoscopic
techniques. Thus, advances in laparoscopic techniques that reduce surgery-related complications would provide
important benefits to the older patient population. Although laparoscopy has generally improved surgical
outcomes, current instruments can contribute to procedure-related complications. To grasp and manipulate
tissue, surgeons typically use the compressive grasper, a tool that pinches tissue between the teeth of two jaws.
While compressive graspers are well-suited for grasping smaller structures, the typical V-shaped jaws only open
to a maximum of 3.5-10 mm apart, so they are not optimized for grasping larger structures, particularly stiff
structures like the inflamed gallbladder. As a result of the compressive grasper’s design, excessive grasping and
retraction forces, long duration of grasps, and slippage of the tissue in the grasper jaws can all contribute to
tissue injury and perforation. In turn, intraoperative tissue damage can lengthen operative time, result in
conversion to traditional open surgery, and increase patient morbidity. In addition to immediately apparent
damage, tissue injury during surgery can result in delayed perforations and significant patient morbidity.
Therefore, the risk of iatrogenic tissue injury is a central and ubiquitous concern for surgeons. To address the
need for a laparoscopic grasper capable of gripping a broad array of tissue types without the risk of slippage or
iatrogenic injury, TheraNova is developing the Lamprey Grasper, a novel, atraumatic laparoscopic grasper. Our
goal is to improve key functionalities within the grasper family, particularly in grasping larger, stiffer structures.
In preliminary studies, we demonstrated that several Lamprey Grasper designs enable a strong, reliable tissue
grasp while inducing less injury than a compressive grasper. The overall goals of this proposal are to build on
this promising work to optimize and validate the Lamprey Grasper. In Specific Aim 1, we will conduct a benchtop
evaluation to identify the optimal Lamprey Grasper design for robust grasping across a range of porcine
abdominal tissues. In Specific Aim 1, we will use the optimal design from Aim 1 to conduct a comprehensive in
vivo evaluation of the Lamprey Grasper vs. a conventional compressive grasper. Two experienced laparoscopic
surgeons will perform a series of laparoscopic actions in Yorkshire pigs (n=6) to compare functionality, usability,
and grasper-induced tissue injury between the two graspers. If this Phase I work is successful, in Phase II we
will conduct a large, post-operative survival animal study to validate the functionality, usability, and safety of the
Lamprey Grasper, which will support a 510(k) submission to the FDA.
摘要
美国每年有多达480万例手术,腹腔镜检查已迅速成为外科标准,
各种各样的程序。与开放手术相比,腹腔镜手术减少了肌肉损伤,
失血量、术后疼痛、并发症发生率和住院时间。然而,腹腔镜手术具有独特的
技术特定的局限性和并发症,因此认为微创手术
创伤是不精确的。现在有证据表明,虚弱,老龄化人口可能受益最多的腹腔镜手术
技术.因此,减少手术相关并发症的腹腔镜技术的进步将提供
对老年患者群体有很大好处。尽管腹腔镜检查总体上改善了手术效果
结果,目前的工具可能导致手术相关并发症。以抓紧和处理
对于组织,外科医生通常使用压缩抓钳,这是一种在两个钳口的齿之间夹紧组织的工具。
虽然压缩抓钳非常适合于抓持较小的结构,但典型的V形钳口仅打开
最大间距为3.5-10 mm,因此它们不适合抓取较大的结构,特别是刚性结构,
比如发炎的胆囊由于压缩抓钳的设计,过度抓持和
回缩力、长时间的抓取以及组织在抓取器钳口中的滑动都可能导致
组织损伤和穿孔。反过来,术中组织损伤会延长手术时间,导致
转换为传统的开放手术,并增加患者的发病率。除了立即明显的
手术期间的损伤、组织损伤可能会导致穿孔延迟和患者严重发病。
因此,医源性组织损伤的风险是外科医生普遍关注的中心问题。解决
需要一种腹腔镜抓钳,其能够抓持广泛的组织类型而没有滑动的风险,
为了避免医源性损伤,TheraNova正在开发Lamprey抓钳,这是一种新型的无创伤腹腔镜抓钳。我们
目标是改善抓钳系列的关键功能,特别是在抓持更大、更硬的结构方面。
在初步研究中,我们证明了几种七鳃鳗抓钳设计能够实现坚固、可靠的组织
抓持,同时比压缩抓持器引起更少的损伤。本提案的总体目标是:
这项有前途的工作,以优化和验证七鳃鳗抓钳。在具体目标1中,我们将进行一个实验台
评估以确定最佳七鳃鳗抓钳设计,用于在一系列猪中进行稳健抓钳
腹部组织在具体目标1中,我们将使用目标1中的最优设计进行全面的研究,
Lamprey抓钳与传统压缩抓钳的体内评价。两名经验丰富的腹腔镜检查员
外科医生将在约克郡猪(n=6)中进行一系列腹腔镜操作,以比较功能性,可用性,
以及两个抓紧器之间的抓紧器引起的组织损伤。如果第一阶段的工作成功,在第二阶段,
将进行一项大型的术后存活动物研究,以验证
七鳃鳗抓钳,将支持向FDA提交510(k)申请。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Jaasma其他文献
Michael Jaasma的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Research Grant














{{item.name}}会员




